Artificial-intelligence-based end-to-end prediction of cancer immunotherapy response
TANGERINE aims to build deep learning models to predict response and toxicity to immune chekpoint blockade therapy in cancer from the analysis of histopathology and radiology images.
TRANSCAN 3 project funded in the 2021 Joint Transnational Call for Proposals (JTC 2021) co-funded by the European Commission/DG Research and Innovation
Website: https://tangerine-ai.eu/
Period: 01/04/2023 - 31/03/2026
This study has been funded by AECC Scientific Foundation through the project TRNSC213877MORE, under the frame TRANSCAN-3 JTC2021 program. We thank CERCA Programme / Generalitat de Catalunya for institutional support.
This study has been funded by Instituto de Salud Carlos III through the project AC22/00021 and funded by European Union - NextGenerationUE
